Medtronic Plc

NYSE: MDT
$83.86
-$0.10 (-0.1%)
Real Time Data Delayed 15 Min.

MDT Stock Chart and Intraday Price

MDT Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Address 20 ON HATCH, LOWER HATCH STREET, DUBLIN, IE
Fiscal Year End April
Latest Quarter 1/31/2024
Market Cap 111,005.75M USD
Shares Outstanding 1,327,820,000
Medtronic Plc is a global leader in medical technology, offering a wide range of device-based therapies for healthcare systems, physicians, and patients. With a focus on improving lives, its product portfolio spans cardiovascular treatments, including pacemakers and stent grafts, surgical solutions like stapling devices and robotic-assisted surgery systems, neuroscience technologies for pain management and spinal procedures, and diabetes management tools such as insulin pumps. Founded in 1949 and based in Dublin, Ireland, Medtronic is dedicated to pushing the boundaries of medical innovation.

MDT Articles

Here are five overlooked Dividend Aristocrats that investors interested in dependable passive income can grab now before Wall Street catches on.
Is it too late for investors to jump on the artificial intelligence bandwagon? There may still be opportunities, like this medical diagnostics company.
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson,...
These five outstanding companies, including a real estate investment trust and a big-box retailer, not only are Wall Street favorites but are expected to boost their dividends this week. That makes...
Monday's top analyst upgrades and downgrades included Ally Financial, Arbor Realty Trust, Azek, Chesapeake Energy, C3.ai, Endeavor, First Solar, Kingsoft Cloud, Kite Realty, Medtronic and Opendoor...
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Carnival, Deere, Delta Air Lines, DexCom, Enovix, First Republic Bank, GitLab, Hartford Financial Services, Interpublic...
Before markets open on Tuesday, these three companies are on deck to report quarterly results.
Wednesday’s additional top analyst upgrades and downgrades were on Home Depot, Intel, Lincoln National, Marvell Technology, Medtronic, Microchip Technology, Nvidia, NXP Semiconductors, ON...
Wednesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Eli Lilly, Home Depot, Medtronic, Palantir Technologies, Snowflake, Take-Two Interactive Software, Viatris and...
Wednesday's top analyst upgrades and downgrades included APA, Edwards Lifesciences, Enterprise Products Partners, Global Payments, International Paper, Johnson & Johnson, Match, Medtronic, Netflix,...
Friday's top analyst upgrades and downgrades included Altice USA, Apple, Colgate-Palmolive, Marathon Petroleum, Mastercard, Medtronic, Meta Platforms, Nike, Prologis, Realty Income, SLM, Tenaris and...
Thursday's top analyst upgrades and downgrades included Boston Scientific, Caesars Entertainment, DraftKings, Fiserv, IBM, Medtronic, Norwegian Cruise Line, Pioneer Natural Resources and Raytheon...